A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease (NCT04540497)

🧪 Interventions in This Study

• Inebilizumab (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (72 Sites)

Showing the first 25 of 72 sites.

• Viela Bio Investigative Site — Palo Alto, California
• Viela Bio Investigative Site — Atlanta, Georgia
• Viela Bio Investigative Site — Baltimore, Maryland
• Viela Bio Investigative Site — Boston, Massachusetts
• Viela Bio Investigative Site — Buenos Aires,
• Viela Bio Investigative Site — Mendoza,
• Viela Bio Investigative Site — Auchenflower, Queensland
• Viela Bio Investigative Site — Adelaide, South Australia
• Viela Bio Investigative Site — Fitzroy,
• Viela Bio Investigative Site — Sherbrooke,
• Viela Bio Investigative Site 1 — Toronto,
• Viela Bio Investigative Site 2 — Toronto,
• Viela Bio Investigative Site — Hohhot, Inner Mongolia
• Viela Bio Investigative Site 1 — Beijing,
• Viela Bio Investigative Site 2 — Beijing,
• Viela Bio Investigative Site 3 — Beijing,
• Viela Bio Investigative Site 4 — Beijing,
• Viela Bio Investigative Site 5 — Beijing,
• Viela Bio Investigative Site — Guandong,
• Viela Bio Investigative Site — Shang’ai,
• Viela Bio Investigative Site — Shenyang,
• Viela Bio Investigative Site — Wuhan,
• Viela Bio Investigative Site — Clichy,
• Viela Bio Investigative Site — Lille,
• Viela Bio Investigative Site — Marseille,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in IgG4 Related Disease

• A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease — Stanford, California
• Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease — Atlanta, Georgia

Explore by condition: All IgG4 Related Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.